These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 32943729

  • 1. Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner.
    Huang Q, Sun Y, Zhai W, Ma X, Shen D, Du S, You B, Niu Y, Huang CP, Zhang X, Chang C.
    Oncogene; 2020 Oct; 39(43):6677-6691. PubMed ID: 32943729
    [Abstract] [Full Text] [Related]

  • 2. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
    Chen Y, Sun Y, Rao Q, Xu H, Li L, Chang C.
    Oncotarget; 2015 Oct 13; 6(31):31203-15. PubMed ID: 26304926
    [Abstract] [Full Text] [Related]

  • 3. Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma.
    Huang Q, Sun Y, Ma X, Gao Y, Li X, Niu Y, Zhang X, Chang C.
    Nat Commun; 2017 Oct 13; 8(1):918. PubMed ID: 29030639
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
    Zhai W, Sun Y, Jiang M, Wang M, Gasiewicz TA, Zheng J, Chang C.
    Oncogene; 2016 Sep 15; 35(37):4866-80. PubMed ID: 26973243
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
    Gunningham SP, Currie MJ, Han C, Turner K, Scott PA, Robinson BA, Harris AL, Fox SB.
    Cancer Res; 2001 Apr 01; 61(7):3206-11. PubMed ID: 11306510
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.
    Sourbier C, Srivastava G, Ghosh MC, Ghosh S, Yang Y, Gupta G, Degraff W, Krishna MC, Mitchell JB, Rouault TA, Linehan WM.
    Oncotarget; 2012 Nov 01; 3(11):1472-82. PubMed ID: 23178531
    [Abstract] [Full Text] [Related]

  • 11. Prolyl Hydroxylase 3 Knockdown Accelerates VHL-Mutant Kidney Cancer Growth In Vivo.
    Zacharias NM, Wang L, Maity T, Li L, Millward SW, Karam JA, Wood CG, Navai N.
    Int J Mol Sci; 2021 Mar 11; 22(6):. PubMed ID: 33799686
    [Abstract] [Full Text] [Related]

  • 12. Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy.
    Yamasaki T, Kamba T, Kanno T, Inoue T, Shibasaki N, Arakaki R, Yamada T, Kondo K, Kamoto T, Nishiyama H, Ogawa O, Nakamura E.
    Cancer Sci; 2012 Nov 11; 103(11):2027-37. PubMed ID: 22931246
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis.
    Gong D, Sun Y, Guo C, Sheu TJ, Zhai W, Zheng J, Chang C.
    Clin Transl Med; 2021 Mar 16; 11(3):e353. PubMed ID: 33783995
    [Abstract] [Full Text] [Related]

  • 19. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M, Sun Y, Xu J, Lu J, Wang K, Yang DR, Yang G, Li G, Chang C.
    Int J Cancer; 2018 Jul 01; 143(1):100-112. PubMed ID: 29396852
    [Abstract] [Full Text] [Related]

  • 20. Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α.
    Fan Y, Li H, Ma X, Gao Y, Bao X, Du Q, Ma M, Liu K, Yao Y, Huang Q, Zhang Y, Zhang X.
    Oncotarget; 2016 Apr 05; 7(14):18280-94. PubMed ID: 26943772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.